LSE •
Healthcare •
Diagnostics & Research •
Quote as of 07/01/2026 10:00
Company Profile
IndustryDiagnostics & Research
SectorHealthcare
ExchangeLSE
Market Capitalization4.29 mln
Float3,060 mln
Earnings Date01/26/2027
Piotroski F-Score
3
/ 9
Below average
Beneish M-Score
-4.62
Highly reliable
Relative Strength
0
/ 100
Severely lagging
Debt / Equity
4.58
Highly leveraged
ROE
-293
Deeply negative
Dividend Yield
0.00%
No dividend
Business Description
Oxford BioDynamics is a UK-based biotechnology company focused on developing blood tests that help doctors make better treatment decisions for patients with serious diseases. Its core technology reads three-dimensional patterns in the genome to predict how individual patients will respond to specific therapies, including cancer immunotherapy. Founded in 2007 and operating across the United Kingdom and the United States, the company combines laboratory diagnostics with cloud-based data tools to bring precision medicine closer to everyday clinical practice.
